NAS:CABA (USA)
Cabaletta Bio Inc $ 10.39 -1.17 (-10.12%)
Volume:
207,132
Avg Vol (1m):
113,832
Market Cap $:
249.94 Mil
Enterprise Value $:
133.19 Mil
PE Ratio:
0.00
PB Ratio:
2.52
Financial Strength | 7/10 |
Current | Vs Industry | Vs History | |
---|---|---|---|
Cash-To-Debt | No Debt | ||
Interest Coverage | No Debt | ||
Altman Z-Score | 0 | ||
Beneish M-Score | 0 | ||
WACC vs ROIC |
Profitability Rank | 1/10 |
Current | Vs Industry | Vs History | |
---|---|---|---|
ROE % | -30.27 | ||
ROA % | -24.48 | ||
ROC (Joel Greenblatt) % | -2763.29 |
CABA
Valuation Rank |
Current | Vs Industry | Vs History | |
---|---|---|---|
PB Ratio | 2.52 | ||
EV-to-EBIT | -4.4 | ||
EV-to-EBITDA | -4.45 | ||
Current Ratio | 27.95 | ||
Quick Ratio | 27.95 |
Dividend & Buy Back |
Current | Vs Industry | Vs History |
---|
Valuation & Return |
Current | Vs Industry | Vs History | |
---|---|---|---|
Price-to-Tangible-Book | 2.53 | ||
Earnings Yield (Greenblatt) % | -22.82 |